Clinical implications of aberrant PD-1 expression for acute leukemia prognosis
| Title: | Clinical implications of aberrant PD-1 expression for acute leukemia prognosis |
|---|---|
| Authors: | Yanjie Ruan, Jiyu Wang, Qiuye Zhang, Huiping Wang, Cong Li, Xuanxuan Xu, Zhimin Zhai |
| Source: | European Journal of Medical Research, Vol 28, Iss 1, Pp 1-10 (2023) |
| Publisher Information: | BMC, 2023. |
| Publication Year: | 2023 |
| Collection: | LCC:Medicine |
| Subject Terms: | PD-1, Acute lymphoma leukemia, Acute myeloid leukemia, CD4+ T lymphocytes, CD8+ T lymphocytes, Prognosis, Medicine |
| More Details: | Abstract Background Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are the most common types of leukemia in adults with an overall poor prognosis. PD-1 alone or combined with other immune checkpoint blockade is a promising research direction for the treatment of acute leukemia (AL) patients. However, clinical Implications of aberrant PD-1 expression in peripheral CD4+ and CD8+ T lymphocytes of AML and ALL patients in assessing the prognosis of diseases, remains inconclusive. Methods In the present study, we used flow cytometry to evaluate PD-1 expression on the surface of CD4+ and CD8+ T lymphocytes in the peripheral circulation of AML and ALL patients and its clinical significance. A total of 53 AML patients, 44 ALL patients and 28 healthy controls were enrolled in this study and peripheral blood specimens were detected by flow cytometry. Results Our results indicated that percentages of CD4+ PD1+ and CD8+ PD1+ T lymphocytes in newly diagnosed and non-remission groups were significantly higher than healthy control both in AML and ALL patients. The high level of CD4+ PD1+ and CD8+ PD1+ T lymphocytes were respectively poor prognostic indicators of AML patients and ALL patients but had no significant correlation with most common clinical risks. Conclusions Our findings show that aberrant PD-1 expression correlates with the prognosis of AL patient and may thus serve as poor prognostic indicators. Immunotherapy using PD-1 inhibitors may be a promising strategy for AML and ALL patients with peripheral circulating CD4+ PD1+ and CD8+ PD1+ T lymphocytes positively expressed, respectively. |
| Document Type: | article |
| File Description: | electronic resource |
| Language: | English |
| ISSN: | 2047-783X |
| Relation: | https://doaj.org/toc/2047-783X |
| DOI: | 10.1186/s40001-023-01352-8 |
| Access URL: | https://doaj.org/article/99b763588e0a4adc85f0051625e593ce |
| Accession Number: | edsdoj.99b763588e0a4adc85f0051625e593ce |
| Database: | Directory of Open Access Journals |
Be the first to leave a comment!